

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb60507</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>A New Specific DNA Target Sequence for Identification of Staphylococcus epidermidis using Modified Comparative Genomic Analysis</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Khoshbakht</surname><given-names>Reza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Zare</surname><given-names>Hosna</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Kamali Kakhki</surname><given-names>Reza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Neshani</surname><given-names>Alireza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Arfaatabar</surname><given-names>Maryam</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>14</volume>
      <issue>3</issue>
      <fpage>216</fpage>
      <lpage>222</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>7</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2022</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &lt;em&gt;Staphylococcus epidermidis (S. epidermidis) &lt;/em&gt;is the most frequently isolated pathogen from prostheses infections in the body. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Therefore, improving its diagnostic methods, including rapid Nucleic Acid Amplification Tests (NAAT), seems necessary. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Since the first step in designing a NAAT is to find a specific sequence and all DNA targets that have been introduced so far are not completely specific, we introduced a new 100% specific DNA target sequence to identify &lt;em&gt;S. epidermidis &lt;/em&gt;in this study.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Modified comparative genomic analysis was used to find the best specific target sequence to detect &lt;em&gt;S. epidermidis&lt;/em&gt;. A PCR method was designed for the evaluation of this target. To determine the detection limit and analytical specificity, pure genomic DNA of 18 bacteria include 12 standard strains (one &lt;em&gt;S. epidermidis&lt;/em&gt; and 11 non-&lt;em&gt;S. epidermidis&lt;/em&gt;) and six clinical isolates (five &lt;em&gt;S. epidermidis&lt;/em&gt; and one non-&lt;em&gt;S. epidermidis&lt;/em&gt;) were used.&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The 400 &lt;em&gt;bp&lt;/em&gt; sequence of &lt;em&gt;S. epidermidis&lt;/em&gt; ATCC 14990 was identified as the most specific sequence (Se400), having a 100% sequence similarity to &lt;em&gt;S. epidermidis&lt;/em&gt; genomes but not with other bacteria. The detection limit of Se400-PCR was 10 &lt;em&gt;fg&lt;/em&gt;, equal to about 4 copies of &lt;em&gt;S. epidermidis&lt;/em&gt; genomic &lt;em&gt;DNA/&amp;mu;l&lt;/em&gt;. All pure DNA templates from &lt;em&gt;S. epidermidis&lt;/em&gt; generated a detectable amplicon by 264 &lt;em&gt;bp&lt;/em&gt; length, but the PCR test was negative for the non-&lt;em&gt;S. epidermidis&lt;/em&gt; group.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The Se400 sequence can be considered as a specific target for detecting &lt;em&gt;S. epidermidis, &lt;/em&gt;based on our findings.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
